BioLife Solutions, Inc.
BLFS
$23.95
-$0.79-3.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 105.75M | 100.31M | 90.65M | 83.97M | 78.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 105.75M | 100.31M | 90.65M | 83.97M | 78.27M |
| Cost of Revenue | 38.39M | 35.64M | 30.84M | 28.09M | 25.61M |
| Gross Profit | 67.37M | 64.67M | 59.81M | 55.88M | 52.66M |
| SG&A Expenses | 56.93M | 55.99M | 55.68M | 52.91M | 50.58M |
| Depreciation & Amortization | 1.56M | 1.54M | -318.00K | -334.00K | -359.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 107.02M | 102.10M | 91.82M | 85.47M | 79.95M |
| Operating Income | -1.26M | -1.79M | -1.17M | -1.50M | -1.68M |
| Income Before Tax | -11.83M | -12.79M | -14.26M | -15.51M | -5.36M |
| Income Tax Expenses | 97.00K | 49.00K | 246.00K | 84.00K | -41.00K |
| Earnings from Continuing Operations | -11.92 | -12.84 | -14.50 | -15.59 | -5.32 |
| Earnings from Discontinued Operations | 8.96M | 8.24M | 11.30M | 10.06M | -5.10M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.96M | -4.60M | -3.21M | -5.53M | -10.41M |
| EBIT | -1.26M | -1.79M | -1.17M | -1.50M | -1.68M |
| EBITDA | 2.74M | 2.02M | 3.76M | 4.42M | 5.21M |
| EPS Basic | -0.06 | -0.10 | -0.06 | -0.11 | -0.23 |
| Normalized Basic EPS | 0.05 | 0.03 | 0.02 | 0.00 | -0.02 |
| EPS Diluted | -0.08 | -0.11 | -0.07 | -0.12 | -0.24 |
| Normalized Diluted EPS | 0.05 | 0.03 | 0.01 | 0.00 | -0.02 |
| Average Basic Shares Outstanding | 192.33M | 191.00M | 189.51M | 187.76M | 185.96M |
| Average Diluted Shares Outstanding | 194.78M | 193.90M | 192.92M | 190.37M | 188.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |